Skip to content

A retrospective observational study of biomarkers in a phase III clinical trial (TRICOLORE study) in the primary treatment of metastatic colorectal cancer

A retrospective observational study of biomarkers in a phase III clinical trial (TRICOLORE study) in the primary treatment of metastatic colorectal cancer - A retrospective observational study of biomarkers in the primary treatment of metastatic colorectal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000053340
Enrollment
370
Registered
2024-01-12
Start date
2023-12-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metastatic colorectal cancer

Interventions

None listed

Sponsors

Tohoku University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Of the patients enrolled in the TRICOLORE study, those who have given consent for ancillary research and for whom various omics data are available will be enrolled in this study.

Exclusion criteria

Exclusion criteria: not applicable

Design outcomes

Primary

MeasureTime frame
Explore novel biomarker-based subtype classification using machine learning causal effect analysis techniques.

Countries

Japan

Contacts

Public ContactKota Ouchi

Tohoku University Hospital Department of Medical Oncology

kota.ouchi.b3@tohoku.ac.jp022-717-8543

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026